We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Zeposia (ozanimod), an oral treatment for relapsing forms of multiple sclerosis. Learn about its benefits, how it works, side effects, and what to expect when managing MS with this medication.
Multiple Sclerosis (MS) is a complex, chronic autoimmune disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. It can lead to a wide range of debilitating symptoms, significantly impacting a person's quality of life. While there is no cure for MS, advancements in medical science have led to the development of various disease-modifying therapies (DMTs) that can help manage the disease, reduce relapse rates, and slow disease progression.
Among these innovative treatments is Zeposia (ozanimod), an oral medication approved for treating relapsing forms of MS. This comprehensive guide will delve into Zeposia, exploring how it works, who it's for, its potential benefits, side effects, and other crucial information for individuals considering or currently using this treatment.
Before we explore Zeposia, it's essential to have a foundational understanding of Multiple Sclerosis itself.
MS is an autoimmune condition where the body's immune system mistakenly attacks the myelin sheath—the protective covering around nerve fibers in the central nervous system. This damage disrupts the communication between the brain and the rest of the body, leading to a variety of neurological symptoms. The damage can also occur to the nerve fibers themselves.
MS symptoms are highly variable and depend on which nerves are affected. Common symptoms include:
The exact cause of MS is unknown, but it is believed to be a combination of genetic predisposition and environmental factors. These may include:
Diagnosing MS involves a thorough neurological examination, medical history review, and several tests:
A definitive diagnosis often requires evidence of demyelination in different areas of the CNS at different points in time.
Zeposia, with the generic name ozanimod, is an oral disease-modifying therapy approved for the treatment of relapsing forms of multiple sclerosis.
Zeposia belongs to a class of drugs known as sphingosine 1-phosphate (S1P) receptor modulators. It works by binding to S1P receptors on certain immune cells called lymphocytes. This binding prevents lymphocytes from leaving the lymph nodes and entering the central nervous system (brain and spinal cord).
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026